{"id":200467,"date":"2022-01-11T14:49:42","date_gmt":"2022-01-11T14:49:42","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=200467"},"modified":"2026-04-08T17:16:52","modified_gmt":"2026-04-08T17:16:52","slug":"veste-uriasa-anuntata-de-pfizer-stirea-a-facut-inconjurul-lumii","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=200467","title":{"rendered":"Veste uria\u015f\u0103 anun\u0163at\u0103 de Pfizer. \u015etirea a f\u0103cut \u00eenconjurul lumii"},"content":{"rendered":"<p>\nPfizer a \u00eenceput dezvoltarea unui vaccin hibrid care combin\u0103 doza ini\u0163ial\u0103 cu o formul\u0103 care protejeaz\u0103 \u00eempotriva variantei Omicron, a declarat CEO-ul gigantului farma, potrivit Bloomberg.<\/p>\n<p>\n\u00cen timp ce cercet\u0103rile continu\u0103, Pfizer va evalua noua formul\u0103 hibrid\u0103 \u00een raport cu o doz\u0103 specific\u0103 Omicron \u015fi va determina care este cea mai potrivit\u0103 pentru a fi scoas\u0103 pe pia\u0163\u0103, a declarat directorul executiv Albert Bourla pe 10 ianuarie la Conferin\u0163a JPMorgan Healthcare.<\/p>\n<p>\nPfizer va fi gata \u00een martie s\u0103 se adreseze autorit\u0103\u0163ilor de reglementare din Statele Unite pentru autorizarea vaccinului modificat. Potrivit doctorului Bourla, produc\u0163ia vaccinului deja a \u00eenceput.<\/p>\n<p>\nPfizer a declarat la sf\u00e2r\u015fitul lunii noiembrie, la scurt timp dup\u0103 ce noua tulpin\u0103 a fost detectat\u0103 pentru prima dat\u0103 \u00een Africa de Sud, c\u0103 lucreaz\u0103 la un vaccin specific \u00eempotriva Omicron.<\/p>\n<p>\nConducerea Pfizer a declarat c\u0103 va continua s\u0103 ofere resurse suplimentare unit\u0103\u0163ii de vaccinare a companiei \u015fi c\u0103 urm\u0103re\u015fte, de asemenea, s\u0103 implementeze tehnologia ARN mesager \u015fi \u00een alte domenii.<\/p>\n<p>\n\u201e\u00cen mod clar, (ARNm) este o tehnologie foarte ofertant\u0103 \u015fi insuficient exploatat\u0103\u201d, a declarat dr. Bourla, conform sursei men\u0163ionate.<\/p>\n<p>\nLuni, Pfizer a anun\u0163at c\u0103 principalele direc\u0163ii de cercetare ale companiei vor fi vaccinurile cu ARNm \u00eempotriva Covid-19, bolile rare \u015fi cancerul.<\/p>\n<p>\nPfizer face, de asemenea, progrese \u00een extinderea accesului la tratamentul s\u0103u oral anti Covid-19, Paxlovid.<\/p>\n<p>\n\u201e\u00cen c\u00e2teva s\u0103pt\u0103m\u00e2ni \u00eel vom avea peste tot, \u201e a spus dr. Bourla despre accesul SUA la noul tratament.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer a \u00eenceput dezvoltarea unui vaccin hibrid care combin\u0103 doza ini\u0163ial\u0103 cu o formul\u0103 care protejeaz\u0103 \u00eempotriva variantei Omicron, a declarat CEO-ul gigantului farma, potrivit Bloomberg. \u00cen timp ce cercet\u0103rile continu\u0103, Pfizer va evalua noua formul\u0103 hibrid\u0103 \u00een raport cu o doz\u0103 specific\u0103 Omicron \u015fi va determina care este cea mai potrivit\u0103 pentru a fi [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[50742,7442,10779,50384,14847,10429,259,7134,106,204,14930],"class_list":["post-200467","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-arnm","tag-dezvoltare","tag-hibrid","tag-omicron","tag-pandemie","tag-pfizer","tag-productie","tag-statele-unite","tag-sua","tag-tehnologie","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/200467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=200467"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/200467\/revisions"}],"predecessor-version":[{"id":200492,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/200467\/revisions\/200492"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=200467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=200467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=200467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}